Modernizing the FDA: An incremental revolution

被引:18
作者
Merrill, RA
机构
关键词
D O I
10.1377/hlthaff.18.2.96
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The U.S. Food and Drug Administration (FDA) is responsible for protecting consumers from unsafe or ineffective drugs and medical devices. The agency's role is defined by a growing and increasingly complex set of statutes, which reflect Congress's desires, on the one hand, to prevent product hazards and, on the other, to expedite FDA review and approval of promising new medical technologies. Congress's latest attempt to calibrate regulation to achieve these goals, the 1997 Food and Drug Administration Modernization Act, endorses certain of the FDA's own innovations and changes in the agency's ways of doing business.
引用
收藏
页码:96 / 111
页数:16
相关论文
共 35 条
  • [1] AUSTERN HT, 1973, FOOD DRUG COSMET LAW, V28, P191
  • [2] BENSON JS, 1994, FOOD DRUG LAW J, V49, P415
  • [3] BRODY B, 1995, ETHICAL ISSUES DRUG, P165
  • [4] *CAN DEP NAT HLTH, 1996, INT COOP AGR MAN, P39
  • [5] Charo R Alta, 1993, St Louis Univ Law J, V38, P135
  • [6] *FDA, 1996, GRAY SHEET 1216, P10
  • [7] *FDA, 1998, FDA ANN REP REV GOOD
  • [8] *FDA, 1998, PINK SHEET 0112, P15
  • [9] *FDA ADV COMM SYST, 1992, FOOD DRUG ADM ADV CO
  • [10] FRIEDMAN M, 1973, NEWSWEEK 0108, P49